检索

期
标题
作者
卷 15, 编号 4 (2013)
The main markers of the long-term efficiency of neoadjuvant chemotherapy in breast cancer (review of literature)
Semiglazov V., Semiglazov V., Paltuev P., Nikolaev K., Dashyan G.
卷 23, 编号 1 (2021)
The frequency and spectrum of PIK3CA mutations in patients with estrogen receptor-positive HER2-negative advanced breast cancer residing in various regions of Russia
Sokolova T., Aleksakhina S., Yanus G., Sultanbaev A., Menshikov K., Lysenko A., Zukov R., Zyuzyukina A., Murunova Y., Rossokha E., Bakharev S., Basova E., Kasmynina T., Shumskaya I., Bakshun Y., Musaeva K., Khasanova A., Dmitriev V., Bolieva M., Gadzaova C., Petrenko O., Maksimov D., Vladimirov V., Goldberg V., Popova N., Kibisheva M., Khamgokov Z., Vasilyev A., Iyevleva A., Imyanitov E.
PDF
(Rus)
卷 22, 编号 4 (2020)
Novel therapeutic strategies for patients with metastatic triple-negative breast cancer
Ganshina I., Gordeeva O., Manukian M.
PDF
(Rus)
卷 20, 编号 1 (2018)
Dermatomyositis and polymyositis in breast cancer patients: a case reports
Ganshina I., Zhukova L., Burnevitch E., Gordeeva O., Kondratieva O.
PDF
(Rus)
卷 18, 编号 2 (2016)
Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with paclitaxel in HER2-positive metastatic breast cancer patients: findings of the international, double-blind phase III clinical study
Ignatova E., Burdaeva O., Kopp M., Kotiv B., Udovitsa D., Stroiakovskii D., Alekseev S., Sheveleva L., Khorinko A., Shapovalova I., Moiseenko V., Ivanov R.
PDF
(Rus)
卷 17, 编号 2 (2015)
Efficacy and safety of extimia® (empegfilgrastim): results of a double-blind controlled phase iii study in patients with diagnosis «breast cancer» receiving myelosuppressive chemotherapy
Krivorotko P., Burdaeva O., Nechaeva M., Frolova M., Kopp M., Abrosimova A., Ivanov R.
卷 17, 编号 1 (2015)
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Semiglazova T., Dashyan G., Semiglazov V., Zhabina A., Osipov M., Kotova Z., Klimenko V., Krivorotko P., Semiglazov V.
卷 16, 编号 3 (2014)
Personalized approach to HER2-positive advanced breast cancertherapy
Stenina M.
卷 23, 编号 1 (2021)
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
PDF
(Rus)
卷 22, 编号 4 (2020)
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N., Artamonova E., Beloyartseva M., Volkova E., Ganshina I., Troshina E., Tjulandin S., Chubenko V.
PDF
(Rus)
卷 20, 编号 2 (2018)
The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)
Stepanova A., Merzlyakova A., Khulamhanova M., Trofimova O.
PDF
(Rus)
卷 19, 编号 4 (2017)
Soft tissue metastases of the gluteal region in HER2+ breast cancer: a clinical case
Kolyadina I., Ganshina I., Zhukova L., Abdullaev A., Andreeva Y., Danzanova T., Sinyukova G., Komov D., Kozlov N., Filonenko D., Gordeeva O., Lubennikova E.
PDF
(Rus)
卷 19, 编号 1 (2017)
Albumin-bound paclitaxel in the treatment of metastatic breast cancer
Artamonova E.
PDF
(Rus)
卷 18, 编号 3 (2016)
The results of epidemiological screening program of HER2 status in patients with breast cancer in the federal districts of the Russian Federation in 2015
Poddubnaya I., Frank G., Yagudina R., Koroleva N., Zavalishina L.
PDF
(Rus)
卷 17, 编号 2 (2015)
Stereotactic biopsy of breast lesions under x-ray control
Manikhas G., Safronova O., Khudjakova T., Barabanova L., Punanova N.
卷 17, 编号 1 (2015)
Breast cancer immunology: theory and prospects (review)
Kolyadina I., Poddubnaya I.
卷 16, 编号 2 (2014)
High efficiency of lapatinib in combination with capecitabine in patient with metastatic HER2-positive synchronous breast cancer (case study)
Seryakov A., Ovchinnikova L., Zabelin M., Yakubov T., Sidorov D., Ovchinnikov M.
卷 15, 编号 2 (2013)
New possibilities of chemotherapy for anthracyclineand/or taxane-resistant breast cancer
Artamonova E., Manzyuk L.
卷 23, 编号 2 (2021)
PIK3CA mutation: changing the paradigm of HR+ HER2-negative metastatic breast cancer therapy. Review of the Novartis Pharma satellite symposium, held as part of a virtual forum dedicated to the diagnosis and treatment of patients with hormone-dependent HER2-negative advanced breast cancer with a PIK3CA gene mutation. April 23, 2021
Board E.
PDF
(Rus)
卷 23, 编号 1 (2021)
Piqray – basic questions at the start: whom to test? whom to treat? how to treat? Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 29th, 2021
Board E.
PDF
(Rus)
卷 22, 编号 4 (2020)
The virtual forum on the diagnosis and treatment of PIK3CA-mutated metastatic breast cancer. October 16th, 2020. Event review
Poddubnaya I., Gligorov J., Zhukova L., Kovalenko E., Frolova M.
PDF
(Rus)
卷 21, 编号 3 (2019)
Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population
Grechukhina K., Zhukova L.
PDF
(Rus)
卷 19, 编号 4 (2017)
Clinical and radiological evaluation the effectiveness of preoperative systemic therapy in different biological subtypes of breast cancer stages T1-3N0-1M0
Pavlikova O., Poddubnaya I., Kolyadina I., Abdullaev A., Komov D., Danzanova T., Sinyukova G., Kozlov N., Ganshina I., Zhukova L., Aliyeva G., Kerimov R., Gordeeva O.
PDF
(Rus)
卷 19, 编号 1 (2017)
Molecular characteristics of premalignant breast lesions
Vysotskaya I., Letyagin V., Pogodina E.
PDF
(Rus)
卷 17, 编号 2 (2015)
Brain metastases in her2-positive breast cancer: new opportunities for systemic therapy
Artamonova E., Manziuk L.
卷 16, 编号 4 (2014)
Male breast cancer: review of the literature
Nikolaev K., Semiglazov V., Semiglazov V.
卷 16, 编号 3 (2014)
Modern treatment possibilities of hormone receptor-positive advanced breast cancer in postmenopausal women
Jackisch C., Llombart-Cussac A.
卷 15, 编号 1 (2013)
Current approach to adjuvant therapy for breast cancer (a review)
Conte P., Guarneri V.
101 - 128 的 128 信息 << < 1 2 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##